BioCentury
ARTICLE | Company News

Genzyme, Genetrix Inc. deal

April 29, 1996 7:00 AM UTC

Genetrix shareholders approved GENZ's acquisition of the privately held company for $36.7 million worth of GENZ common in a tax free transaction. GENZ will issue about 705,770 shares to close the deal...